# Regulatory Compliance — Cold Chain Monitor

**Domain:** iot
**Solution ID:** 058
**Generated:** 2026-03-22T11:53:39.325016
**HITL Level:** standard

---

## 1. Applicable Standards

- **GDP**
- **WHO Technical Report**
- **21 CFR Part 211**
- **IEC 62443**

## 2. Domain Detection Results

- iot (from solution definition)

## 3. Compliance Task Coverage

Tasks in the build plan that address compliance requirements:

| Task | Type | Description | Compliance Relevance |
|------|------|-------------|---------------------|
| Step 2 | SAFETY | Perform hazard analysis and risk assessment for cold chain monitoring device per | Risk management, FMEA, hazard analysis |
| Step 3 | COMPLIANCE | Produce GDP compliance framework mapping: WHO Technical Report 961 Annex 9, EU G | Standards mapping, DHF, traceability |
| Step 5 | SECURITY | Perform threat model (STRIDE) for the cold chain system per IEC 62443. Cover dev | Threat modeling, penetration testing |
| Step 12 | EMBEDDED_TEST | Write HIL (Hardware-in-the-Loop) test suite for sensor node firmware: sensor dri | Hardware-in-the-loop verification |
| Step 15 | SYSTEM_TEST | Execute end-to-end system test: real firmware on sensor node transmitting to bac | End-to-end validation, performance |
| Step 16 | COMPLIANCE | Generate IEC 62443 compliance evidence package: security assessment report, zone | Standards mapping, DHF, traceability |

**Total tasks:** 17 | **Compliance tasks:** 6 | **Coverage:** 35%

## 4. Compliance Checklist

| # | Requirement | Status | Evidence | Responsible Agent |
|---|------------|--------|----------|-------------------|
| 1 | GDP compliance verified | PENDING | Build plan includes relevant tasks | regulatory_specialist |
| 2 | WHO Technical Report compliance verified | PENDING | Build plan includes relevant tasks | regulatory_specialist |
| 3 | 21 CFR Part 211 compliance verified | PENDING | Build plan includes relevant tasks | regulatory_specialist |
| 4 | IEC 62443 compliance verified | PENDING | Build plan includes relevant tasks | regulatory_specialist |

## 5. Risk Assessment Summary

**Risk Level:** STANDARD — Compliance focus on data protection and quality

| Risk Category | Mitigation in Plan |
|--------------|-------------------|
| Data Privacy | SECURITY + LEGAL tasks |
| Service Quality | QA + SYSTEM_TEST tasks |
| Compliance Gap | REGULATORY tasks (if applicable) |

## 6. Agent Team Assignment

| Agent Role | Tasks Assigned | Team |
|-----------|---------------|------|
| developer | 6 | Engineering |
| regulatory_specialist | 3 | Compliance |
| qa_engineer | 2 | Engineering |
| product_manager | 1 | Design |
| safety_engineer | 1 | Compliance |
| firmware_engineer | 1 | Engineering |
| devops_engineer | 1 | Engineering |
| system_tester | 1 | Engineering |
| technical_writer | 1 | Operations |

## 7. Critic Review (Actor-Critic Assessment)

**Plan Score:** 54/100 (FAIL) — 1 iteration(s)

**Summary:** This plan demonstrates serious domain knowledge across hardware, firmware, backend, compliance, and security — the 17-step structure is logical and the acceptance criteria are more specific than most plans at this scope. However, it fails at the exact points where pharmaceutical cold chain regulation is unforgiving. The LLM confidence-score-as-compliance-verdict in step 10 is a fundamental design error that would block regulatory submission in any GDP jurisdiction; no inspector will accept 'AI says 95% confident' as a compliance gate. The missing 21 CFR Part 11 / EU Annex 11 scope is a critical omission for pharma customers — electronic signature requirements on audit trail entries are non-negotiable. The absence of a device calibration management workflow is a GDP showstopper: sensor readings without traceable calibration certificates are inadmissible as evidence. Hardware procurement is never planned yet HIL testing is mandated, making step 12 unexecutable. For a regulated domain requiring 85+, this plan scores 54 — the engineering fundamentals are solid but the compliance and regulated-system gaps represent rework at the architecture level, not minor additions.

### Flaws Identified

1. Step 10 uses LLM 'confidence_score >= 0.95' as a GDP compliance gate. LLMs do not produce calibrated confidence scores. This criterion is meaningless and would be immediately rejected by any regulatory inspector. A GDP compliance verdict requires a Qualified Person (QP) signature, not an AI convergence metric.
2. Step 5 assigns 'regulatory_specialist' as the agent role for STRIDE threat modeling. STRIDE is a security engineering discipline. This skill mismatch means the threat model will be superficial and compliance-framed rather than adversarial.
3. Step 7 implements both BLE and LoRaWAN radio stacks with no gateway architecture decision. These are fundamentally different topologies (BLE needs a nearby gateway; LoRaWAN is direct to network server). Implementing both without specifying when each is used doubles radio driver complexity and adds a fleet management dimension not addressed anywhere.
4. Step 8 defines the audit_log table as 'INSERT-only' but Step 9 acceptance criteria require a 'cryptographic hash chain' for tamper evidence. The hash chain columns (prev_hash, entry_hash) are not in the database schema design. The schema in step 8 will not support the tamper-evident requirement in step 9.
5. Step 9 sets '1000 concurrent device connections' as an acceptance criterion but Step 15 load-tests only 500 devices. These targets contradict each other. The load test will not validate the stated requirement.
6. Step 9 says 'device ingestion endpoint (MQTT/HTTP)' treating them as interchangeable. MQTT is a broker protocol; HTTP is request-response. Bridging EMQX (step 14) to FastAPI requires an explicit MQTT subscriber service that is never specified in the backend architecture.
7. Step 12 is labeled 'HIL (Hardware-in-the-Loop)' but there is no hardware procurement or bring-up step anywhere in the plan. Real HIL requires physical sensor nodes, JTAG debug probes, and a hardware test bench. This step cannot execute without hardware that was never planned.
8. Step 6 specifies excursion event simulation 'triggers within 500ms' but Step 7 firmware acceptance criteria say 'within 1 sample period' (which at 1-minute interval is 60 seconds). The simulation and firmware specifications are 120x apart with no reconciliation.
9. Step 4 sets up CI/CD before the threat model (step 5) is complete. The CI pipeline will lack security scanning gates derived from the threat model, meaning the pipeline is configured without knowing what it needs to enforce.
10. Step 16 claims IEC 62443-3-3 Security Level 2 verification as a deliverable but SL2 requires formal organizational security policies, incident response procedures, and security program documentation that are not created anywhere in the plan. 'Verification' cannot precede the policy artifacts it verifies.

### Suggestions

1. Replace the LLM confidence score gate in step 10 with a deterministic rules engine for GDP threshold checking. Reserve the actor-critic loop for generating the narrative report only. The compliance verdict must be a human QP decision, not an AI score.
2. Add a dedicated PKI and device identity provisioning step between steps 4 and 5. Device certificates, root CA, provisioning HSM, and certificate rotation policy are critical path items for TLS mutual auth and secure boot — and are currently assumed to exist without being built.
3. Resolve the BLE vs LoRaWAN architecture decision in step 4 before implementing dual radio stacks in step 7. Choose one primary radio per deployment scenario and treat the other as a future option, or specify the gateway topology that connects both.
4. Add ALCOA+ hash chain columns (entry_hash, prev_hash, signed_by) to the step 8 database schema and implement a database-level trigger that computes them on INSERT. The audit trail's tamper evidence must be in the schema, not bolted on later.
5. Add a hardware procurement and bring-up step before step 6. Specify the target hardware (STM32L476 dev board + SHT41 eval kit + u-blox EVK), the bring-up acceptance criteria, and the JTAG/SWD debug probe required for HIL in step 12.
6. Add an excursion disposition workflow to the backend (step 9) and frontend (step 11). GDP requires documented QP review of each excursion — decision on product release/quarantine with signature — before shipment closure. This workflow is the core regulated process and is absent.
7. Add a device calibration management module: NIST-traceable calibration certificates, calibration due-date tracking, in-field drift detection algorithm, and automated alert when a device exceeds calibration interval. This is mandatory for pharmaceutical cold chain evidence.
8. Add 21 CFR Part 11 and EU Annex 11 compliance to step 3. If US pharma companies are customers, electronic records and electronic signatures (e-sig with audit trail) are required for the audit trail and compliance reports. These are distinct from GDP and currently unaddressed.
9. Specify NTP or GNSS-disciplined time sync in the firmware (step 7) and a server-side timestamp reconciliation algorithm. Offline buffering for 72 hours with a potentially drifted device clock will produce timestamp errors in the audit trail unless explicitly corrected.
10. Add a data residency and sovereignty analysis to step 3. GPS tracks of pharmaceutical shipments crossing EU borders are GDPR-scoped personal data (driver location). Cloud region selection and data processing agreements must be specified before backend deployment.

### Missing Elements

1. 21 CFR Part 11 / EU Annex 11 compliance for electronic records and electronic signatures — mandatory if US or EU pharma QA systems will rely on this data
2. Device calibration management: NIST-traceable certificates, calibration intervals, drift detection, recalibration workflow
3. PKI infrastructure: root CA, device certificate provisioning at manufacturing, certificate rotation, revocation
4. Excursion disposition workflow: QP review, product release/quarantine decision, documented rationale, e-signature
5. Hardware procurement and bring-up plan — prerequisite for all HIL testing
6. Time synchronization specification and clock drift reconciliation for offline-buffered data
7. Gateway architecture decision and specification (BLE gateway fleet vs LoRaWAN network server)
8. IQ/OQ/PQ (Installation/Operational/Performance Qualification) for cloud infrastructure — required for GxP-validated computer systems
9. Data residency and GDPR analysis for cross-border shipment GPS tracking
10. Battery and power-loss handling: graceful shutdown, flash commit before power cut, corruption recovery on boot
11. Sensor calibration drift detection algorithm in firmware (SHT41 accuracy degrades without periodic recalibration)
12. Multi-tenant / multi-customer data isolation design if this is a SaaS cold chain service

### Security Risks

1. No certificate rotation mechanism specified for device TLS identity. Devices in the field for 5+ years (matching the 5-year data retention requirement) will have expired certificates with no rotation path defined.
2. MQTT broker (EMQX) authentication model is unspecified. If devices authenticate with shared credentials or username/password rather than mutual TLS client certificates, a single compromised device credential exposes all device identities.
3. GPS spoofing countermeasure in step 5 is listed as an acceptance criterion but no concrete detection algorithm is specified — just 'countermeasure specified.' GPS spoofing in pharmaceutical cold chain could falsify chain-of-custody location data, which has direct GDP compliance consequences.
4. OTA firmware update in step 7 specifies hash validation and rollback but does not specify the signing key management, key ceremony, or HSM requirements. If the signing key is compromised, malicious firmware can be pushed to the entire device fleet.
5. The 'immutable audit log' relies on a PostgreSQL trigger preventing UPDATE/DELETE. This is bypassable by any database superuser. True tamper evidence requires an append-only log with cryptographic chaining written by the application layer, not just a trigger that a DBA can disable.
6. HashiCorp Vault in step 14 is listed as the secrets manager but no unsealing strategy, high-availability configuration, or Vault DR plan is specified. Vault becoming unavailable would take down all backend services that depend on dynamic secrets.
7. No rate limiting or device authentication throttling specified for the ingestion endpoint. A compromised device identity could flood the ingestion pipeline, triggering a data loss or DoS scenario that masks a real excursion event.


## 8. Audit Trail

- **Generated by:** SAGE Build Orchestrator v2.0
- **Timestamp:** 2026-03-22T11:53:39.325048
- **Pipeline:** Domain Detection → Plan Decompose → Critic Review → HITL Approve → Scaffold → Execute → Integrate → Finalize
- **Approval gates:** All build artifacts subject to HITL approval
- **Critic threshold:** 70/100 (actor-critic review required before human approval)
